Nov 16, 2016 by Brian Feroldi3 Stocks That Doubled in 2016It's been a blissful year for shareholders of these three companies.
Nov 16, 2016 by Brian Feroldi2 Stocks That Quadrupled Over the Past 5 YearsBoth of these stocks have been home run investments, but can the gains continue from here?
Nov 15, 2016 by Brian Feroldi, Matt DiLallo, and Steve Symington3 Stocks at 52-Week Highs Still Worth BuyingWhile it may defy conventional wisdom, buying stocks that are trading near their 52-week high can often be a profitable decision.
Nov 14, 2016 by Brian FeroldiWhy bluebird bio Inc. Stock Jumped TodayThe clinical-stage biotech continues to move erratically ahead of the upcoming ASH meeting.
Nov 14, 2016 by Brian FeroldiWhy PTC Therapeutics Is Soaring AgainShares jump after an analyst issues a bullish outlook for the company's stock.
Nov 12, 2016 by Brian Feroldi3 Stocks That Don't Need President Trump to Do WellThe country's near-term future may be uncertain, but these three companies should continue to do well in almost any political environment.
Nov 11, 2016 by Brian Feroldi, Matt DiLallo, and Timothy Green3 Top Stocks to Buy for Your KidsAre you interested in giving your kids a financial head start in life? If so then buying them a few shares of these three companies might be a smart decision.
Nov 11, 2016 by Brian Feroldi3 Highest Growth Stocks in the Market TodayThese three companies are growing fast, but are any actually worth owning?
Nov 11, 2016 by Brian FeroldiThe Likely Reason Why Novavax, Inc. Sank Another 26.9% in OctoberVolatility continues to remain high for the beleaguered biotech, which contributed to shares falling yet again.
Nov 11, 2016 by Brian FeroldiWhy Novo Nordisk A/S Stock Dropped 13.6% in OctoberShares tumbled after management poured cold water on the company's long-term growth targets.
Nov 10, 2016 by Brian FeroldiWhy Zeltiq Aesthetics Inc. Is Soaring TodayShares jump in response to a strong third-quarter earnings report.
Nov 10, 2016 by Brian FeroldiNovoCure Ltd. Fell 29.7% in October -- but Why?Shares of the commercial-stage medical-device company fell hard despite good news.
Nov 9, 2016 by Brian FeroldiWhy Keryx Biopharmaceuticals Stock Jumped TodayNews of a resolution to its supply disruption issue caused shares to climb higher.
Nov 9, 2016 by Brian FeroldiWhy Arrowhead Pharmaceuticals Inc. Is Plummeting TodayNews that the FDA has placed one of the company's clinical trials on hold sends shares tumbling.
Nov 9, 2016 by Brian FeroldiHere's Why Keryx Biopharmaceuticals Fell 18% in OctoberShares were hit hard by the general sell-off in the biotech sector.
Nov 8, 2016 by Brian FeroldiWhy Did Halozyme Therapeutics, Inc. Plunge 29.5% in October?Shares of the small-cap biotech fell hard despite producing little news.
Nov 8, 2016 by Brian FeroldiRegeneron Pharmaceuticals, Inc. Dropped 14.3% in October -- Here's WhyTwo disappointing updates caused shares to tumble.
Nov 8, 2016 by Brian FeroldiIs Illumina Inc. a Buffett Stock?How does the genomic sequencing specialist stack up against Buffett's acquisition criteria?
Nov 7, 2016 by Brian FeroldiWhy Coherus BioSciences, Inc. Is Dropping TodayShares plunge on news of an unfavorable ruling issued by the U.S. Patent Office.
Nov 7, 2016 by Brian FeroldiAlkermes PLC: Sales Rise, Losses Fall, and the Pipeline Moves ForwardThe biopharma continues to make good progress with its pipeline as it slowly inches towards profitability.
